Gemcitabine and cisplatin in a concomitant alternating ...

Gemcitabine and cisplatin in a concomitant alternating ... - PubMed

Methods and materials: Patients with squamous cell carcinomas of the oral cavity, pharynx and larynx, bulky T4, and/or N2 to N3 were eligible. Gemcitabine was ...

Purpose: Administration of gemcitabine together with cisplatin at cytotoxic doses in a chemoradiotherapy regimen is hampered by a high degree of local ...

Gemcitabine and cisplatin in a concomitant alternating ...

Purpose: Administration of gemcitabine together with cisplatin at cytotoxic doses in a chemoradiotherapy regimen is hampered by a high degree of local ...

gemcitabine and cisplatin with concurrent radiotherapy for treatment ...

Gemcitabine alternating with cisplatin concurrent with radiotherapy is an active and safe treatment that deserves further study.

Chemotherapy alternating gemcitabine and cisplatin concomitant ...

40%of the patients stopped treatment for one or two weeks due to toxicity without affecting the doses of both treatments. Conclusions: The scheme with ...

Clinical investigation Head and neck Gemcitabine and cisplatin in a ...

Clinical investigation. Head and neck. Gemcitabine and cisplatin in a concomitant alternating chemoradiotherapy program for locally advanced head-and-neck ...

Alternating gemcitabine and cisplatin with gemcitabine and radiation ...

... concomitantly with chemotherapy. Finally, we do not know if the addition of induction chemotherapy to a concomitant chemoradiation approach may improve the ...

GEMCITABINE AND CISPLATIN IN A CONCOMITANT ...

GEMCITABINE AND CISPLATIN IN A CONCOMITANT ALTERNATING. CHEMORADIOTHERAPY PROGRAM FOR LOCALLY ADVANCED. HEAD-AND-NECK CANCER: A PHARMACOLOGY-GUIDED SCHEDULE.

(PDF) Gemcitabine and cisplatin in a concomitant alternating ...

Patients with squamous cell carcinomas of the oral cavity, pharynx and larynx, bulky T4, and/or N2 to N3 were eligible. Gemcitabine was ...

Gemcitabine and cisplatin in a concomitant alternating ... - OSTI.GOV

Title: Gemcitabine and cisplatin in a concomitant alternating chemoradiotherapy program for locally advanced head-and-neck cancer: A pharmacology-guided ...

Gemcitabine and cisplatin in a concomitant alternating ...

Gemcitabine and cisplatin in a concomitant alternating chemoradiotherapy program for locally advanced head-and-neck cancer: a pharmacology-guided schedule.

Weekly cisplatin or gemcitabine concomitant with radiation in the ...

Gemcitabine may be used as an alternative to cisplatin in patients with compromised renal function. Key Words: Chemoradiation, Locally advanced carcinoma cervix ...

Gemcitabine–cisplatin: A schedule finding study - Annals of Oncology

Patients and methods: Forty-one patients with advanced solid tumors received alternating sequences with a 4- and. 24-hour interval of cisplatin and gemcitabine.

Adjuvant cisplatin–gemcitabine as an alternative for cisplatin ... - BJMO

Despite the current practice of using a concurrent adjuvant cisplatin–fluorouracil regimen, patients with N2–3 nasopharyngeal carcinoma have a high-risk of ...

Chemotherapy alternating gemcitabine and cisplatin concomitant ...

Request PDF | Chemotherapy alternating gemcitabine and cisplatin concomitant with radiotherapy in locally advanced (LA) squamous cell carcinoma of the head ...

Durvalumab plus Gemcitabine and Cisplatin in Advanced Biliary ...

First-line standard of care for advanced biliary tract cancer was established more than 10 years ago from the ABC-02 trial, which demonstrated a ...

Weekly full-dose gemcitabine and single-dose cisplatin with ... - Nature

Patients received gemcitabine (1000 mg m−2 on days 1, 8, 15, 29, and 36) and cisplatin (70 mg m−2 on days 1 and 29) with concurrent radiotherapy ...

Split-dose cisplatin as an alternative to every-3-week dosing when ...

Split-dose cisplatin as an alternative to every-3-week dosing when using cisplatin/gemcitabine to treat advanced urothelial cancer. Authors: Cinthia Marie ...

Gemcitabine and cisplatin in a concomitant alternating ... - OSTI.GOV

Purpose: Administration of gemcitabine together with cisplatin at cytotoxic doses in a chemoradiotherapy regimen is hampered by a high degree of local ...

Gemcitabine, Cisplatin, and nab-Paclitaxel for the Treatment of ...

A phase 1/2 trial reported a high response rate (RR) with gemcitabine-cisplatin plus nab-paclitaxel administration in advanced pancreatic cancer ...